Akron Pharma, Inc. has recalled approximately 331,707 bottles of Acetaminophen 325 mg and 500 mg (Extra Strength) tablets because the tablets are missing the "AP 325" brand identification imprint. Without this imprint, consumers and healthcare providers cannot easily verify the medication if it is removed from its original packaging. No incidents or injuries related to this issue have been reported to date.
The absence of a brand imprint can lead to the misidentification of the drug, which may cause a consumer to take the wrong medication or an incorrect dosage. This is particularly dangerous if multiple medications are stored outside of their original bottles.
You have 2 options:
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.